🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "focused steps to deal with household expense challenges" in the forthcoming Budget.

Speaking to the BBC, she noted that curbing inflation is a shared task of both the government and the Bank of England.

The UK's inflation rate is projected to be the highest among the Group of Seven advanced economies this year and next.

Potential Energy Bill Measures

Reports indicate the administration could take action to lower energy bills, for instance by cutting the present 5% level of VAT charged on energy supplies.

A further approach is to lower some of the policy costs currently added to household expenses.

Budgetary Limitations and Analyst Predictions

The administration will obtain the latest report from the official forecaster, the OBR, on Monday, which will clarify how much space there is for these measures.

The consensus from the majority of experts is that Reeves will have to announce higher taxes or spending cuts in order to adhere to her voluntary debt limits.

Previously on the same day, analysis indicated there was a £22bn shortfall for the chancellor to fill, which is at the lower end of expectations.

"There's a joint job between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While a great deal of the attention has been on expected tax rises, the Treasury chief said the latest information from the OBR had not altered her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with rising international and commercial concerns for the Budget revenue measures, probably to be focused on those "most able to pay."

Global Trade Tensions

Referring to concerns about the UK's commercial links with the Asian nation she said: "Our security interests invariably come first."

Last week's announcement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are crucial for high-technology production led American leader the US President to suggest an additional 100% import tax on imports from China, increasing the risk of an all-out commercial conflict between the two economic giants.

The American finance chief described China's decision "commercial pressure" and "a international production power grab."

Questioned on considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the world economy and generates further headwinds."

"I believe there are areas where we must address Chinese policies, but there are also significant chances to trade with China's economy, including financial services and other sectors of the economy. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "on our own essential resources strategy, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also admitted that the cost the National Health Service spends on medicines could rise as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

A number of the world's largest drug companies have said in recent statements that they are either pausing or scrapping operations in the United Kingdom, with several attributing the insufficient payments they are obtaining.

Recently, the government science advisor said the cost the NHS spends on drugs would have to go up to prevent firms and drug research funding leaving the UK.

Reeves informed media: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been provided in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to make sure that individuals receiving treatment from the NHS are able to obtain the best critical medicines in the world. And so we are reviewing all of that, and... aiming to secure more funding into the UK."